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3D Printing promises to produce complex biomedical devices according to computer design using patient-specific
anatomical data. Since its initial use as pre-surgical visualization models and tooling molds, 3D Printing has slowly
evolved to create one-of-a-kind devices, implants, scaffolds for tissue engineering, diagnostic platforms, and drug
delivery systems. Fueled by the recent explosion in public interest and access to affordable printers, there is
renewed interest to combine stem cells with custom 3D scaffolds for personalized regenerative medicine. Before
3D Printing can be used routinely for the regeneration of complex tissues (e.g. bone, cartilage, muscles, vessels,
nerves in the craniomaxillofacial complex), and complex organs with intricate 3D microarchitecture (e.g. liver,
lymphoid organs), several technological limitations must be addressed. In this review, the major materials and
technology advances within the last five years for each of the common 3D Printing technologies (Three Dimensional
Printing, Fused Deposition Modeling, Selective Laser Sintering, Stereolithography, and 3D Plotting/Direct-Write/Bioprinting)
are described. Examples are highlighted to illustrate progress of each technology in tissue engineering, and key
limitations are identified to motivate future research and advance this fascinating field of advanced manufacturing.
Keywords: 3D Printing, Fused deposition modeling, Selective laser sintering, Stereolithography, Computer-aided tissue
engineering, 3D plotting, BioprintingIntroduction
The ability to design and fabricate complex, 3D biomed-
ical devices is critical in tissue engineering. Applications
for 3D biomedical devices are restoration of 3D anatomic
defects, the reconstruction of complex organs with intri-
cate 3D microarchitecture (e.g. liver, lymphoid organs),
and scaffolds for stem cell differentiation. An example of a
need is anatomic defects in the craniomaxillofacial complex
caused by cancer, trauma, and congenital defects. Proper res-
toration of these defects requires functional nerves, vessels,
muscles, ligaments, cartilage, bone, lymph nodes and glands.
In recent years, various approaches based on tissue en-
gineering principles have been explored to regenerate
other functional tissues that are relevant to maxillofacial
tissue regeneration. In tissue engineering, scaffolds are
critical to provide structure for cell infiltration and pro-
liferation, space for extracellular matrix generation and
remodeling, biochemical cues to direct cell behavior, and
physical connections for injured tissue. When making* Correspondence: benwu@ucla.edu
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unless otherwise stated.scaffolds, design of the architecture on the macro, micro,
and nano level is important for structural, nutrient
transport, and cell-matrix interaction conditions [1-3].
The macroarchitecture is the overall shape of the device
which can be complex (e.g. patient and organ specificity,
anatomical features). The microarchitecture reflects the
tissue architecture (e.g. pore size, shape, porosity, spatial
distribution, and pore interconnection). The nanoarchi-
tecture is surface modification (e.g. biomolecule attach-
ment for cell adhesion, proliferation, and differentiation).
Although an ideal scaffold will account for all these
factors, challenges still exist with biomaterial selection and
3D shape specificity. Biomaterials commonly used are
polymers (synthetic and natural), ceramics, and metals.
Each biomaterial has specific material and mechanical
properties, processing methods, chemical properties, cell-
material interactions, and FDA approval. Common fabri-
cation methods to produce porosity and a range of pores
size are gas foaming, solvent casting with particle leaching,
freeze-drying, and eletrospinning. While the microarchi-
tecture in these methods is well-controlled and under-
stood, the ability to control macroarchitecture with these
methods is limited to 3D shapes and geometries deter-
mined by molds and manual processing. The ability tol. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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also limited when using these methods.
Solid free form fabrication (SFF) has allowed for the de-
sign and fabrication of complex 3D structures which can
be patient specific. The integration of computer aided
design, advanced imaging techniques (i.e. magnetic reson-
ance imaging and computer tomography), and rapid
prototyping has advanced fabrication of objects with both
macro and microarchitecture control. In addition, patient
specific imaging can be used to customize builds for indi-
viduals [4,5]. A type of rapid prototyping, SFF offers a
method to control both the micro and macroarchitecture
to create complex biomedical devices. Most surface modi-
fications can be completed in post-processing. While con-
ventional material processing techniques can be highly
effective in scaffold engineering, SFF technologies offer ex-
citing opportunities for tissue engineering of highly com-
plex maxillofacial tissues. However, each technology has
its limitations. The selection of the fabrication technique
depends upon the materials of interest, machine limita-
tions, and the specific requirements of the final scaffold.
The term “3D Printing” should be clarified to prevent
confusion in this review article. Currently in literature
and mainstream media, the term “3D Printing” is being
used to refer to all SFF technologies (e.g. fused depos-
ition modeling, selective laser sintering, etc.). In this re-
view, the term will be used in two ways: to generally
refer to all SFF technologies and to refer to the liquid
binder-based inkjet technology which is described in de-
tail below. The use of the term will be clear in the differ-
ent sections.
The state of the art 3D Printing, especially for the pro-
duction of implantable biomedical devices, is severely
limited by printable materials. Therefore in most cases,
alternative material processing methods are required to
work with materials that are not easily printed. In cases
where materials can be printed, 3D Printing is particu-
larly advantages for one-of-a-kind, customized complex
devices that are not cost effective in conventional manu-
facturing methods such as injection molding.
While industrial 3D printers have reached extremely
high resolution in the past few years, the advancements
in machine capability have not translated to the use with
biomaterials. Industrial 3D printers can now reach ex-
tremely small build layers such as 16 μm layer thickness
for SLA (Polyjet, Stratasys), 178 μm layer thickness for
FDM (Fortus 900mc, Stratasys), 80 μm layer thickness
for SLS (sPro 230HS, 3D Systems) and 75 μm resolution
for SLA (3D Systems). These systems unfortunately are
not optimized for biomaterials of interest for in vitro
and in vivo studies and advances are still being made to
improve SFF methods for biomaterials.
The cost of each of these technologies is currently dif-
ficult to compare since many advances are based onhome-made setups or modification of commercial ma-
chines by creative engineers. Actual cost will be easier to
compare when the materials become available for large
scale adaptation for industrial 3D printers. That stage
will also determine the ease of use for both printing and
post-processing. Even with current modeling materials,
most printers require some type of sacrificial support
materials that require careful removal
SFF methods, particularly FDM, have recently ex-
ploded in popularity and gone viral. Machines are being
developed specifically for home, school, and small busi-
ness use with much lower price points and less complex-
ity than industrial grade machines. In addition, low-cost
consumer 3D scanners and free CAD software has
allowed those interested in SFF to design and fabricate
parts themselves at home. While these technologies were
previously mainly limited to academia and industry, SFF
has burst into mainstream use and many more people
now understand the capability of the technologies.
This review focuses on advanced 3D Printing tech-
nologies that are being used to fabricate tissue engineer-
ing scaffolds, with emphasis on their ability of these
manufacturing technologies to pattern cells and multiple
materials along complex 3D gradients. Many of these
technologies are already used for making patient specific
models for pre-surgical planning, surgical templates and
prosthesis fabrication. Some already gained FDA clear-
ance for implantable devices. In particular, work done in
the last five years will be highlighted to show the pro-
gression of the field.
3D printing of tissue engineering scaffolds
Most SFF methods build 3D biomedical devices in a layer-
by-layer process. The general SFF process involves 1)
creating a 3D computer model (can be generated from
medical imaging data such as CT scans or X-rays) 2) sli-
cing the 3D computer model into a build file of 2D images
with software, 3) fabricating the build by a computer-
controlled layer-by-layer process, and 4) finishing with any
post processing such as surface modification for nanoarch-
itecture. Complicated three-dimensional features such as
internal voids, cantilevers, undercuts, and narrow tortuous
paths are simply reduced to a stack of common two-
dimensional features such as circles, lines, and points.
Exempted from tooling path restrictions, these additive
technologies offer much higher levels in shape complexity.
Although these SFF technologies were developed primarily
for industrial applications, their flexibility in creating com-
plex three-dimensional shapes make SFF technologies
attractive candidates for biomedical engineering. Various
SFF techniques were introduced to build objects with con-
trolled macroarchitecture as well as microstructures with
biomedical and tissue engineering applications. The free-
dom in form, combined with the appropriate material
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eering triad by simultaneously directing the spatial distri-
bution of cells, signals, and scaffolding substrates during
fabrication. Furthermore, these technologies allow in-
tegration between digitized medical imaging data with
computer-aided-design models [5,6]. The integration of
SFF technologies with patient-specific medical imaging
data enables the aseptic manufacturing of tissue engineer-
ing grafts that match precisely to a patient’s contours can
be produced by. These technologies enable the fabrication
of multi-functional scaffolds that meet the structural,
mechanical, and nutritional requirements based on opti-
mized models [7].
For this review, a brief overview of five popular SFF
technologies will be described, and examples of tissue
engineering applications are provided. For each technol-
ogy, recent advances in machine capability and printable
biomaterials will be reviewed.
Three dimensional printing
Technology description and application
Invented at the Massachusetts Institute of Technology,
Three Dimensional Printing (3DP) fabricates 3D structures
by inkjet printing liquid binder solution onto a powder bed
[8-10]. A wide range of materials has been utilized in print-
ing since most biomaterials exist in either a solid or liquid
state. The process begins by spreading a layer of fine pow-
der material evenly across the piston. The X-Y positioning
system and the printhead are synchronized to print the de-
sired 2D pattern by selective deposition of binder droplets
onto the powder layer (Figure 1) [11]. The piston, powder
bed, and part are lowered, and the next layer of powder is
spread. The drop-spread-print cycle is repeated until the
entire part is completed. Removal of the unbound powder
reveals the fabricated part. The local composition can be
manipulated by specifying the appropriate printhead to de-
posit the predetermined volume of the appropriate binder.
The local microstructure can be controlled by altering the
printing parameters during fabrication [12]. The incorpor-
ation of micro-channels effectively distributed additionalFigure 1 3D Printing schematic. 3D printing is a layer-by-layer
process of depositing liquid binder onto thin layers of powder to
create a 3D object. Reproduced with permission from [11].seeding surfaces throughout the interior of the device,
increasing the effective seeding density and uniformity.
Patterned surface chemistry potentially offers spatial
control over cell distribution of multiple cell type. This
technology is limited by the competing needs between
printhead reliability and feature resolution, as small noz-
zles can make finer features but are more prone to
clogging. Current limitation in resolution is 100 μm for
one-dimensional features (e.g. width of the thinnest print-
able line), and 300 μm for three dimensional features (e.g.
thickness of thinnest printable vertical walls).
Fabrication of complex scaffolds such as internal chan-
nels or hanging features is easily achievable with this
technique, since objects are being supported by sur-
rounding unbounded powders. Kim et al. created highly
porous scaffolds in combination with particulate leach-
ing techniques by 3DP and demonstrated cell ingrowth
into the scaffolds [13]. Also, room temperature process-
ing conditions allow the incorporation of temperature
sensitive materials such as pharmaceutical and biological
agents into scaffolds [10]. Lam et al. fabricated starch-
based scaffolds by printing distilled water, demonstrating
the feasibility of using biological agents and living cells
during fabrication [14]. Another favorable characteristic
of this technology for tissue engineering is multi-“color”
printing where each color ink can be positioned on a
precise location. This feature offers the exciting potential
to simultaneously arrange multiple types of cells, deposit
multiple extra cellular matrix materials, and exert point-
to-point control over bioactive agents for biological tis-
sue manufacturing. In this respect, 3DP may be more
flexible for printable material selection than other SFF
technologies. A wide range of biological agents such as
peptides, proteins (e.g. fibrinogen, collagen), polysaccha-
rides (e.g. hyaluronan, alginate), DNA plasmids, and liv-
ing cells have been printed with 3DP. Deposition of
these biological materials requires modification of indus-
trial 3DP machines. Cells in particular must be kept in a
proper environment with appropriate temperature, oxy-
genation, and nutrient supply.
Other materials previously used in direct 3DP include
powder composed of a synthetic polymer (i.e. poly (ε-
caprolactone), polylactide–coglycolide or poly (L-lactic
acid)) with organic solvent as binder [10,13,15] and nat-
ural polymer powder (i.e.starch, dextran and gelatin) with
water as binder [14,16]. Indirect 3DP prints a mold which
is then cast with the final polymer and porogen materials.
Materials previously used in indirect 3DP to print the
mold include commercially available plaster powder (i.e.
calcium sulfate hemihydrate plaster powder) and water-
based binder. The mold is then cast with a slurry of
biodegradable polymer dissolved in solvent mixed with
porogen (i.e.polylactide–coglycolide in chloroform mixed
with NaCl) [17,18]. The resulting porous scaffold can be
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neers have used 3DP to fabricate porous ceramic scaffolds
with fully interconnected channels directly from hydroxy-
apatite (HA) powder for bone replacement [16]. Custom-
ized anatomically shaped HA constructs can be fabricated
based on medical information from a patient. This technol-
ogy also allows a construction of a biphasic scaffold to re-
generate hybrid tissue systems such as temporomandibular
joint (TMJ). Sherwood et al. have developed osteochondral
composite constructs in which the upper region is com-
posed of D,L-PLGA/L-PLA with 90% porosity for cartilage
regeneration, and the lower region is composed of a L-
PLGA/TCP composite to maximize bone ingrowth [19]. A
highly porous scaffold was created using this 3DP technol-
ogy in combination with a particulate leaching technique.
This problem was addressed by a practical, indirect
3DP protocol, where molds are printed and the final ma-
terials are cast into the mold cavity [17,18]. In the indir-
ect technique, molds are printed using commercially
available plaster powder, and biodegradable polymers are
cast into the printed mold. Many different materials can
be cast under the similar printing process parameters,
whereas individual process parameters need to be opti-
mized to maximize the build resolution in a conven-
tional direct 3DP approach. This technology could be
applied to treat patients with zygomatic bone fractures.
Lee et al. demonstrated the ability of the indirect 3DP
approach to build zygoma scaffold directly from CT data
which can be seen in Figure 3 [17].Figure 2 PLGA scaffold with villi-shaped pillars created from indirect
porogen and polymer dissolved in solvent by indirect 3DP. The resulting sc
interconnectivity (b). Reproduced with permission from [17].An advantage of direct 3DP is direct control over both
the microarchitecture (i.e. pore size) and macroarchitecture
(i.e. overall shape). Prints which use porogen as the powder
result in high pore interconnectivity, uniform porosity, and
defined pore size after leaching. This method has shown to
fabricate scaffolds which can support hepatocyte ingrowth
[13]. Unlike indirect 3DP, there are no limitations on the
macroarchitecture and no need for demolding. One limita-
tion of direct 3DP is that organic solvents can dissolve
polymers used in most printheads. To overcome this limi-
tation, investigators used stencils to pattern polymer solu-
tions onto porogen particles (NaCl) to fabricate scaffolds
[13]. However, the use of stencils prevents fabrication of
highly complex shapes or small features. Organic solvent-
compatible, high precision printheads are available but they
are optimized for a narrow range of polymeric solutions.
Another limitation of direct 3DP is that layer thickness
must be greater than porogen particle size, and less than
150 μm maximum threshold to maintain interlayer con-
nectivity and part strength during printing [12]. To over-
come this porogen size limitation, larger pores must be
printed. One drawback of 3DP is a limited available pore
size in the final constructs when porogens are incorporated
into powders prior to fabrication [15]. The shape complex-
ity of scaffolds is also limited when the powder material is
degradable polymer. Also, this 3DP approach for degrad-
able polymer demands the use of organic solvents as liquid
binders. Since organic solvents can dissolve most commer-
cially available drop-on-demand printhead components,3D Printing. Scaffolds are created by packing a 3D printed mold with
affolds have the desired villi-shaped pillars (a) and high porosity and
Figure 3 3D printed scaffolds can be patient-specific. A zygoma was generated from CT 2D images (a,b) and zygoma-shaped scaffold was
produced from indirect 3DP (c). Reproduced with permission from [17].
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high resolution jets through stencils [15]. However, this ap-
proach is impractical for complicated structures. Indirect
3DP overcomes many of the limitations of direct 3DP. In
the indirect technique, molds are printed using commer-
cially available modeling materials such as plaster, and bio-
degradable polymers are cast into the printed mold. Many
different materials can be cast under the similar printing
process parameters, whereas individual process parameters
need to be optimized to maximize the build resolution in a
conventional direct 3DP approach. This technology could
be applied to treat patients with zygomatic bone fractures.
The use of aqueous binder allows the use of consumer
grade inkjet printheads, and eliminates the need for stencils
[17]. The porogen size is not limited since it is introduced
into the mold cavity after printing, and does not affect
printing resolution or layer interconnectivity. High mate-
rials flexibility with polymer-porogen combinations is
possible due to independence from powder material prop-
erties. This method can be used to create small, high aspect
ratio features (i.e. small intestine villi) or large scale, highly
porous scaffolds (i.e. anatomically shaped zygoma scaffoldswith pore sizes 300-500 μm) [18]. The limitations of indir-
ect 3DP are 1) challenges in uniform, high density packing
of porogen in complex features (i.e. intricate internal un-
dercuts or intersecting channels) and 2) restrictions on
shape or feature design due to difficulty demolding. Incom-
plete packing will result in loss of uniform microarchitec-
ture and desired macroarchitecture.
The key advantages of 3DP are the wide range of mate-
rials able to be used due to room temperature processing
and the material used in powder form, ability to print
overhangs and internal architecture, and microstructure
control. The disadvantages of 3D Printing are the limited
use of organic solvents as binders due to dissolving of
commercial printheads and difficulty in removing un-
bound powder from small or curved channels.
Recent material and technology advances
3DP materials include calcium polyphosphate and PVA
[20], HA and TCP [21-25], TCP [26-29], TCP with SrO
and MgO doping [30,31], HA and apatite–wollastonite
glass ceramic with water-based binder [32], calcium
phosphate with collagen in binder [33], PLGA [34], and
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indirect 3DP gelatin preforms replaced with PCL and chi-
tosan [36]. In vitro studies with bovine chondrocytes for
articular cartilage tissue engineering [20], bone tissue
engineering [21,22,25,26,37], monocytic cells from the
RAW 264.7 cell line [22], human osteoblasts [23,29,32,34],
C2C12 pre-myoblastic cell line [24], and bone marrow
stromal cells [36]. In vivo studies have been performed
with rabbit calvarial bone [26], rabbit tibia bone and por-
cine maxillary bone [24], rat femoral defects [28,30],
mouse femoral defects [33], and rabbit femoral bone [31].
Fused deposition modeling
Technology description and application
Fused deposition modeling (FDM) is the deposition of
molten thermoplastic materials through two heated extru-
sion heads with a small orifice in a specific laydown pat-
tern [38]. One nozzle deposits the thermoplastic material
and the second deposits temporary material to support
cantilevers. In FDM, one of the traditional methods melts
thermoplastic polymer into a semi-liquid state and the
head extrudes the material onto the build platform
(Figure 4) [39]. The part is built in a layer-by-layer fashion
where the layers are fused together. Since multiple extru-
sion nozzles could be used in FDM, each with a different
material, there is no theoretical restriction on com-
positional gradients in all three dimensions for FDM.
However, this has not been reduced to practice.
The most important material selection criteria for
FDM materials are heat transfer characteristics and rhe-
ology (behavior of liquid flow). Thermoplastics are com-
monly used due to the low melting temperature. PVC,
nylon, ABS, and investment casting wax have beenFigure 4 Fused deposition modeling schematic. In fused deposition mo
through a nozzle in a specific lay-down pattern to create a scaffold. Reprinsuccessfully used. For bioapplications, PCL is commonly
used due to its low melting temperature of ~60°C, low
glass transition temperature of -60°C, and high thermal
stability [38,40]. PLGA previously has been used with
FDM to create scaffolds, however, the high glass transition
temperature of PLGA (40-60°C) makes processing PLGA
challenging with a higher extrusion temperature required
[41,42]. The material is heated to ~110-140°C to create
the right material flow properties for extrusion from the
nozzle and fusion of the layers [38,40-42]. Rheological
modifiers can be used but must be biocompatible.
Controllable variables are raster thickness, raster gap
width (space between rasters), raster angle, and layer
thickness (dependent on extrusion tip diameter). This
results in scaffolds with controlled pore size, morph-
ology, and interconnectivity. The extruded molten liquid
must be hot enough to rapidly induce fusion with previ-
ously extruded material and solidify quickly to minimize
flow and feature size. In addition, the viscosity of the
material is critical to be both high enough to allow ex-
trusion through a fine nozzle and low enough to
Scaffolds with biocompatible materials have been made
with different pore morphology and channel sizes by
controlling the x-y movement of the extrusion head [38].
Materials can also be combined in this technology such as
poly(ethylene glycol) terephthalate/poly(butylene tereph-
thalate) or polypropylene/TCP [43,44]. Other composites
such as PCL/HA or PCL/TCP are used with FDM due to
favorable mechanical and biochemical properties for bone
regeneration [45].
The key advantages of FDM are high porosity due to
the laydown pattern and good mechanical strength. A
challenge for FDM is the limitation to thermoplasticdeling, a filament of thermoplastic is heated into liquid and extruded
ted with permission from [39].
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high enough viscosity to build but low enough viscosity
for extrusion. Also, these properties have limited shape
complexity for biological scaffolding materials and typic-
ally result in relatively regular structures [40]. It should
be noted that geometric complexity is not limited for
FDM using industrial materials which are selected to
have optimal thermal and rheological properties but lack
biocompatibility. Another disadvantage for FDM is the
inability to incorporate living cells or temperature sensi-
tive biological agents during extrusion due to the high
processing temperature.
Recent material and technology advances
FDM has commonly used biocompatible polymers with
low melting temperatures. Materials used in FDM to
create scaffolds are PCL and bioactive glass composites
[46], L-lactide/e-caprolactone [46], PLGA with collagen
infiltration [47], PCL-TCP with gentamicin [48], PCL-
TCP [49], PLGA-TCP and coated with HA[42] , PCL-
PLGA-TCP [50], PLGA-PCL [51], PCL coated with
gelatin [52], PCL [53,54], PMMA [55], and PLA [46]. In
vitro studies have been performed with porcine chon-
drocytes [47], mouse pre-osteoblasts [52], and bone
marrow-derived mesenchymal stem cell [53]. In vivo
studies with murine animal models for wound healing
[48], human patient for craniofacial defect [49], and
rabbit bone defect [42,50]. Applications include cartilage
tissue engineering, antibiotic delivery system[48], osse-
ous craniofacial defects in humans [49,55], and bone tis-
sue engineering [13].
While the number of FDM filaments are increasing
every month, the material choices pale in comparison to
the total number of theromoplastics that can be formed
by conventional injection molding. One recent advance
may vastly increase the range of materials available for
3D Printing, and transform it from a prototyping
method to a viable manufacturing method is to incorp-
orate precision injection molding into 3D Printing gan-
try. This combination has significant potential because itFigure 5 Stereolithography schematic. Stereolithography is the polymer
laser (left) or top-down setup with digital light projection (right). Reproduccan process most thermoplastics that exist as conven-
tional injection molding pellets, without pre-processing
into fine powders or traditional FDM filaments. It is es-
sentially mould-free injection molding of final structures,
making it feasible to fabricate one-of-a-kind, one patient
at a time medical device [56].
Stereolithography
Technology description and application
Stereolithography (SLA) is the regarded as the first rapid
prototyping process and was developed in the late 1980s
[57]. The original SLA rasters a HeCd-laser beam to
spatially control the polymerization of photocurable
resin in 2D patterns [58]. After each layer is cured, the
platform with the cured structure attached then lowers
in the bottom-up approach and another layer of uncured
liquid resin spreads over the top. The topmost layer is
now ready to be patterned. For the top-down approach,
light is projected onto a transparent plate initially posi-
tioned near the bottom of the vessel holding the liquid
resin (Figure 5) [59]. After a layer is patterned through
the transparent plate, the cured structure is detached
from the transparent plate. The cured structure is raised
to allow uncured liquid resin to fill the space between
the structure and transparent plate. The next layer is
now ready to be patterned. Since rastering a laser beam
can be slow, especially for large parts, the masked lamp
technique was developed to cure an entire layer of pho-
topolymers at a time. After the structure is built, the
unpolymerized liquid resin is removed by draining. Post-
curing in a UV oven converts any unreacted groups and
strengthens the part [60].
Kinetics of the curing reactions occurring during
polymerization is critical. This affects the curing time
and the thickness of the layer polymerized. The kinetics
can be controlled by the power of the light source, the
scanning speed and the chemistry and amount of the
monomer and photointiators. In addition, UV absorbers
can be added to the resin to control the depth of
polymerization [61].ization of photocurable resin by a bottom-up system with scanning
ed with permission [59].
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crosslinking. Typical materials used in STL include
acrylics and epoxies. For tissue engineering applications,
there are very few biodegradable and biocompatible bio-
materials that are dimensionally stable during photopoly-
merization. Photocrosslinkable poly(propylene fumarate)
(PPF) [62] is commonly used in SLA and has been used to
fabricate complex 3D scaffolds with controlled micro-
structures for reconstruction of rabbit cranial defects [58].
PPF requires a reactive diluent, such as diethyl fumarate
or N-vinyl-2-pyrrolidone, to reduce the viscosity of the
resin for proper processing conditions [63]. These diluents
introduce significant amounts of a non-degradable com-
ponent. Resins with and without bioceramic dispersions
have been processed by SLA.
Medical applications of SLA include the fabrication of
anatomical models for pre-surgical planning, and indir-
ect fabrication of medical devices by using the SLA pat-
terns for molds (e.g. filling a SLA structure to use as a
negative mold) [64,65] . Titanium dental implant com-
ponents have been fabricated by electrical discharge ma-
chining of titanium ingot based on a SLA model.
The advantages of SLA are the ability to create com-
plex shapes with internal architecture, ease of removal
of unpolymerized resin, and extremely high feature reso-
lution (~1.2 um) [66]. The main disadvantage of SLA is
the scarcity of biocompatible resins with proper SLA
processing properties. Additional challenges are the use
of photointiators and radicals which may be cytotoxic
(with long processing times), entrapment of unreacted
monomer and residual photoinitiator, and inability to
create compositional gradients along horizontal planes.
Photopolymerized resin also has poor mechanical prop-
erties that are needed for hard tissue engineering. Lastly,
temporary support structures must be incorporated into
the CAD model to fabricate unsupported features (e.g.
overhangs, cantilevers). Complete removal of support
structures may be difficult.
Recent material and technology advances
Recent improvements for SLA have been increasing the
library of photocrosslinkable polymers and the use of
multiple resins for one build. Over the last few years,
more polymers are synthesized containing aliphatic poly-
esters which allow for biodegradation. The resulting
macromer is then acrylated to allow for photocrosslink-
ing capability. The use of multiple resins for one build
was shown with patterning PEG-DMA and PEG-DA
with fluorescently labeled dextran, fluorescently labeled
bioactive PEG or bioactive PEG in different regions of
the scaffold [67]. When changing material, the scaffold
would be removed from the pool of resin, rinsed with
distilled water, and new resin added to the vat. A fixture
was used to maintain X-Y registration of the scaffold toensure alignment of layers. Dynamic mask projection
SLA has been able to achieve a lateral resolution of ∼ 2
μm, and vertical resolution of ∼ 1 μm for PPF resin [68].
The microstructures able to be produced with this tech-
nology are extremely detailed although there are still
challenges of creating horizontal channels and prevent-
ing shrinkage of structures.
SLA recently has increased the library of resins with
biodegradable moieties and the encapsulation of cells
during processing. Novel macromers synthesized include
segments of PCL (three-armed hydroxyl-terminated)
[69] or poly(D,L-lactide) [63,70,71]. Photo-curable poly
(D,L-lactide) (PLLA) resin without the use of reactive
diluents has been developed and applied in SLA [70].
The end groups are modified to acrylate or methacrylate
to allow for photo-crosslinking capability. Another resin
recently used in making SLA scaffolds is PPF-DEF [72,73]
and PPF-DEF with BMP-2 loaded PLGA microspheres
[74]. PPF-DEF or PPF-DEF with HA is used in μSL (<5
μm resolution) although shrinkage of the polymer occurs
to cause warping of the parts [68,75]. Poly(trimethylene
carbonate) macromers have been used for flexible, elastic
applications with stiffness of 22-156 kPa [76] such as for
cartilage tissue engineering [77]. Stiffer structures have
been studied in vitro with mouse pre-osteoblasts [70], hu-
man umbilical vein endothelial cells [78], rat bone marrow
cells [73], MC3T3-E1 pre-osteoblasts [63,72,74], and hu-
man mesenchymal stem cells[71]. A large application of
SLA is bone tissue engineering [79] and in vivo studies
have shown promoted bone formation in rat cranial de-
fects [74]. For softer, flexible applications such as cartilage
tissue engineering in vitro studies have been performed
with bovine chondrocytes [77]. Cell seeding and cul-
turing was found to be improved with scaffolds with
SLA-controlled pore network architecture compared to
scaffolds made from salt leaching with poly(D,L-lactide)
oligomers and PFF-DEF [73,80]. Cell encapsulation during
SLA has been shown with PEG-DA with NIH/3T3 cells
[81] and PEG-DMA with human chondrocytes although
with an inkjet printer [82].
Selective laser sintering/melting
Technology description and application
Selective laser sintering (SLS) was develop by the University
of Texas in 1989. SLS is similar to 3DP in binding together
powder particles in thin layers except a CO2 laser beam is
used (Figure 6) [83]. The laser scans the surface of the pow-
dered polymer particles in a specific 2D pattern to sinter by
heating them above the glass transition temperature. Dur-
ing sintering, molecular diffusion along the outermost sur-
face of the particle lead to neck formation between
neighboring particles. After one layer is created, the piston
containing the part is lowered and a fresh layer of powder
material is rolled across the top surface. The subsequent
Figure 6 Selective laser sintering schematic. Selective laser
sintering uses a laser to fuse together powder particles to create a
3D scaffold. Thin layers of powder are spread between each fused
layer. Reprinted with permission from [83].
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bound, loose powder is removed after the part is com-
pleted and is heat treated to achieve full density.
Temporary support structures are not needed, unlike in
SLA, since unbound solid particles support any cantilever
structures. Since sintering does not result in complete
melting of the powder particle, the porosity between the
original particles can be preserved, and a wide range of
pure and mixture of materials can be processed.
While solid state sintering can be achieved for most
materials between 0.5-1 Tmelting, selective laser melting
(SLM) and electron beam melting (EBM) use intense en-
ergy to heat the powder above Tmelting to completely fuse
the particles into one fully-dense, consolidated structure.
In In practice, melting is more easily accomplished if all
powder has a single melting point, and is therefore more
easily accomplished with pure metals than with alloys
due to variation in liquid metal flow behavior, surface
tension, and laser-material interactions. Therefore, the
range of materials for SLM is more limited than SLS.
The resolution of features is determined by powder par-
ticle size, focused laser beam diameter and heat transfer in
the powder bed. The limit to particle size is 10 um due to
poor spreading and sintering too quickly causing edge in-
accuracies. Materials commonly used are PCL and a com-
bination of polyether ether ketone and hydroxyapatite
[84-87]. With biomaterials, thin solid disks are commonly
made but feature are made on the ~400-500 μm scale.
Previously coated ceramic powders and thermoplastics
have been used in SLS. Intermediate binding materials are
required because of an excessively high glass transition
temperature and the melting point of ceramic powder.
The intermediate binding materials would melt before the
ceramic powder and fuse together the ceramic particles.
Tan et al. fabricated calcium phosphate bone implants by
sintering calcium phosphate powder coated with polymer
[88]. After the part is built and excess powder removed,post processing (e.g. extra sintering in an oven) in-
creases part strengths but can cause shrinkage of the
parts. A biocomposite blend of polyvinyl alcohol (PVA)
and hydroxyapatite (HA) was also used in SLS [89]. HA
particles were coated with a water-soluble PVA via
spray-drying or physical blending. These parts were
used for craniofacial and joint defect applications.
Williams et al. fabricated PCL scaffolds with porous
architecture and sufficient mechanical properties for
bone tissue engineering applications [90].
This technique is also feasible with medical data to cre-
ate anatomy specific structures. A mandibular condyle
scaffold was demonstrated in this technique using CT data
from a pig condyle [90]. The integration of computational
design and SLS techniques enables the ability to fabricate
scaffolds that have anatomically shaped external architec-
tures and porous interior structure. FDA clearance was re-
cently awarded for the use of SLS to process medical
grade polyether ether ketone (PEEK) to make custom cra-
niofacial implants. More recently, SLM was used to create
the first patient-specific, ready for implantation titanium
mandible that accepts dental implants to support a man-
dibular denture [91].
They key advantage of SLS/SLM/EBM is the ability to
directly make metallic implants that promote either bone
ingrowth and regeneration for load-bearing applications in
which high fracture toughness and mechanical strength
are needed. Even for non-load bearing applications, poly-
mers can be processed without the use of organic solvent.
It is slightly easier to achieve compositional gradients in
SLS than SLA by spreading different powder between dif-
ferent vertical layers, but compositional gradients in the
horizontal plane is very limited. The main disadvantages
are limited materials which fuse but do not decompose
under the laser beam (high temperatures) and the post
processing needed to remove trapped powder. Another
limitation is the condution and diffusion of laser heat
causes unwanted fusion of neighboring powder particles,
limiting the resolution of final features. Lastly, smaller
pore sizes are limited since the created pores depend on
the particle size of the powder used. Powder particles too
small cannot be used due to poor spreading from powder
clumping.
Recent material and technology advances
Recent advances of SLS have been the ability to produce
lower stiffness scaffolds and higher resolution features.
PCL scaffolds have been produced at lower stiffness of
300-400 kPa [87] than reported before at 14.9-113.4
MPa [85,86,90,92]. This lower stiffness allows for appli-
cations of soft tissue engineering such as cardiac tissue.
Work has been done to streamline the CAD/CAM
process of making functionally graded scaffolds (FGS,
changing stiffness within a part) by using a library of
Figure 7 Bioprinting schematic. In bioprinting, small balls of
bioink composed of cells and hydrogel materials (e.g. alginate or
decellularized extracellular matrix) are printed in a desired shape.
Reproduced with permission from [11].
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processed is related to the stiffness of the scaffold and
demonstrated with PCL in SLS [93]. A thorough review
on the development of the design of microarchitecture
can be found [94]. In addition, FEA has been used to
help design microarchitecture and predict mechanical
properties for SLS [92,95].
For SLS, common materials used are PCL and HA
[92,96,97], PCL and β-TCP with collagen coating [98],
Ca-P/PHBV and CHAp/PLLA [99,100], and PVA [101].
To demonstrate encapsulation of biomolecules, BSA was
encapsulated in Ca-P/PHBV microparticles and processed
[102]. In vitro studies have been performed with C2C12
myoblast cells for cardiac tissue engineering [87], SaOS-2
cells [99], human bone marrow stromal cells [103], and
human osteoprogenitor cells [52], porcine adipose-derived
stem cells [98,104], and MG-63 [101] for bone tissue en-
gineering. In vivo studies have been performed in nude
mice showed better woven bone and vascular tissue for-
mation [98]. Applications are bone tissue engineering and
interbody cages for spinal fusions [97].
3D Plotting/Direct-write bioprinting
Technology description and application
3D plotting was developed at the Freiburg Materials
Research Center in 2000 to create soft tissue scaffolds. 3D
plotting is based on extruding a viscous liquid material
(generally a solution, paste, or dispersion) from a pressur-
ized syringe into a liquid medium with matching density.
The material is deposited in one long continuous strand
or in individual dots from a nozzle or syringe to create a
desired 3D shape of ceramics, polymers, or hydrogels
[105]. The process can be at room temperature or at ele-
vated temperatures, but does not involve thermoplastics
as in FDM.
This SFF method is particularly applicable for natural
biomaterials to create hydrogels. Landers et al. used ther-
moreversible natural polymers such as agar and gelatin in
solution. The solution is heated and extruded at ~80°C
into a cooler liquid medium (~20°C) of gelatin or silicone
oil to quickly solidify the heated solution. [106,107]. An-
other approach is to extrude polymers into a liquid
medium containing reactants for crosslinking. An example
material is extruding gelatin into a Ca2+ reservoir for mi-
crovasculature [108]. For other materials such as TCP, a
solution is made with water, extruded from a syringe, and
then lyophilized to remove the liquid [109]. The resulting
diameter of each strut was ~400 μm.
The key advantages are material flexibility and room
temperature processing (if applicable). In addition, many
of the other SFF technologies cannot use natural poly-
mers due to processing conditions. One key disadvan-
tage is the difficulty in fabricating complex shapes with
overhangs since a temporary, sacrificial material isneeded. In addition, hydrogels created in this method
have low stiffness which may result in collapse of struc-
tures or limitations on complexity of shapes.
Similarly, bioprinting is the fabrication of hydrogel
structures with direct incorporation of cells (Figure 7).
Cells are added during processing in cell printing strat-
egies such as alginate-cell (bovine chondrocytes) solution
extruded from a syringe [110], electrostatically driven ink-
jet printing of bovine vascular endothelial cells in culture
medium [111], laser-guided direct writing of embryonic
chick spinal cord cells [112], and laser-induced forward
transfer of cells suspended in alginate [113]. This technol-
ogy provides a controlled spatial distribution of cell or
growth factors as well as the scaffold structures. However,
this fabrication technique is generally limited to hydrogel
materials such as alginate and fibrin, which may not be
ideal for the implantation in biological environments that
require strong mechanical properties. Example applica-
tions are rat smooth muscle cell-laden collagen droplets
(650 μm diameter) to create specific cell spatial patterns in
3D [114]. This SFF method is especially good for low vis-
cosity materials and the buoyancy due to the density
matching of the extruded material to the liquid medium
prevents collapse of the shape. The strand thickness can
be varied by material viscosity, deposition speed, extrusion
tip diameter, and applied pressure.
The key advantages of bioprinting are the room tem-
perature processing (if applicable), direct incorporation
of cells, and homogenous distribution of cells. The key
disadvantages are limited mechanical stiffness, critical
timing of gelation time, specific matching of material
and liquid medium densities to preserve shapes, and low
resolution. Further development of materials that are
optimal for biofactor printing, and next generation print-
heads that can separately deposit multiple biofactors and
materials onto the same platform, will provide the
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logical requirements of tissue engineering scaffolds.
Recent material and technology advances
Bioplotting materials include PLGA, TCP, collagen and
chitosan [109], chitosan [115], collagen-alginate-silica
composites coated with HA [116], soy protein [117,118],
and agarose with gelatin [107]. In vitro studies have been
performed with mouse pre-osteoblasts [116] and human
mesenchymal stem cells [117]. In vivo studies have been
performed in ovine cavalarial defects [109]. Applications
include bone tissue engineering [109,116], tissue regen-
eration [118].
Bioprinting materials are agarose with human umbil-
ical vein smooth muscle cells (HUVSMCs) and human
skin fibroblasts (rods) [119], gelatin-HA-tetraPEG-DA
with NIH 3T3s (rods) [120], rat primary bladder smooth
muscle cells in collagen droplets [114], human micro-
vascular endothelial cells in fibrin (inkjet printer) [121],
and alginate droplets [108]. Applications are mainly for
vascular tissue engineering [108,119-121].
Recent studies show the ability to bioprint single cells
and cell-laden hydrogel-PCL scaffolds. High throughput
printing of single-cell arrays has been shown with
“Block-Cell-Printing” [122]. Microfluidic arrays of hook-
shaped traps are used to trap single cells. Trapped cells
can be paired and separated 5 μm to study cell com-
munication. In this study, trapped primary rat cortical
neurons were cultured and cells exhibited neuronal
morphology. Ahn et al. bioprinted high density cell-
laden hydrogels by extruding a 4°C cell-alginate solution
onto a -10°C stage to create a structure [123]. The algin-
ate was crosslinked to provide strength by incubating
the structure in a CaCl2 solution. Good cell viability of
was shown for human mesenchymal stem cells and
human osteoblast-like cells after processing. Lastly, a layer-
by-layer process has alternately deposited chondrocyte-
laden hydrogel droplets (alginate or decellularized
extracellular matrix bioink) and PCL in a layer-by-layer
process to create a 3D structure [124-126] (Figure 7).
Recent advances in biofactor printing technology allow
the simultaneous printing of pharmaceutical and bio-
logical agents during fabrication. Xu et al. demonstrated
that inkjet printing technology can precisely place the
cells and proteins into 3D alginate structures [127].
Future direction
Additional progress for 3D Printing technologies is
needed for increasing resolution without sacrificing
shape, strength, and handability of scaffolds. Anatom-
ical features and tissue architecture may have details on
the scale of hundreds of microns (e.g. villi of the small
intestine with ~500 um diameters). Diffusion consump-
tion modeling has shown a 200 μm limit in scaffoldsfor oxygen transport to cells, resulting in a maximum of
400 μm diameter features for cell survival [128]. For both
SLS and 3DP, there is a challenge with creating stronger
structures without increasing dimensions. To create small
features which survives the fabrication process, powder
particles much be bound together tightly. By increasing
the strength of the laser for SLS or amount of binder for
3DP, additional powder particles would bind and therefore
increase the dimensions. Additional work is needed to
move SLS and 3DP to resolutions below 400-500 μm. In
addition, unbound trapped powder is difficult to remove
from small channels. Future work is needed to create pow-
der that is easily removable with traditional methods of
high-pressured air. One strategy is to create spherical
powder particles which would facilitate removal in tight
spaces.
While SLA can reach extremely high resolutions, there
are a limited number of biodegradable, biocompatible
resins. Advances have been made to synthesize new
macromers with biodegradable moieties, however, these
materials have not been FDA approved. FDM, SLS, and
3DP are able to use polymers such as PLGA, PLLA, and
PCL without chemical modification which will help ex-
pedite future FDA approval for biomedical devices.
Although macro and microarchitecture has made great
strides in the past five years, additional work should
focus on the nanoarchitecture (e.g. biochemical mole-
cules). Due to harsh processing conditions of SFF
methods (e.g. heat, organic solvent), biochemical mole-
cules are not generally incorporated directly into the
scaffold. While biochemical molecules can be coated
onto structures in post-processing, there is a need for
sustained growth factor release over time. Therefore,
strategies to incorporate biochemical molecules directly
into scaffolds for prolonged release will be needed.
Although the focus of this review article is on the fabri-
cation techniques and biomaterials used in 3DP, the deg-
radation kinetics and byproducts of the materials are in
fact a very significant problem in 3D scaffolds due to mass
transport limitations within thick scaffolds. This is a mov-
ing boundary diffusion-reaction problem that even with-
out biodegradable biomaterials can result in hypoxia and
acidosis within the scaffolds. The release of acidic degrad-
ation products is expected to worsen the acidosis which
may harm the seeded cells and/or the surrounding cells”.
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